LinkedIn
WebsiteIntroduction to VSee Health Inc.
VSee Health Inc. (NASDAQ: VSEE) is a San Jose-based developer of a modular, HIPAA-compliant telehealth platform. Founded in 2008, the company offers no-code and low-code building blocks—APIs, SDKs, and turnkey modules—for video visits, scheduling, patient engagement, device integration, and EHR interoperability. Key clients include NASA’s International Space Station medical team, the U.S. Department of Health and Human Services, McKesson, DaVita, and the country of Qatar.
Corporate Structure and Experience
VSee operates as a privately held company with 51 to 200 employees. Its workforce includes software engineers, product managers, clinical services specialists, and customer support teams. The platform has been deployed by more than 2,000 organizations globally, delivering over 1.5 million HIPAA-compliant video encounters each month. The company is headquartered in San Jose, California.
Telehealth by National Cancer Institute
Recent Developments and News
- 2025-04-02: A PR Newswire release detailed VSee’s modular telehealth strategy, announcing contracts including a $444,000 county government mental health platform, a $560,000 oncology network deployment, and a $2 million program for neurocritical care robotics.
- 2025-10-14: The company filed an 8-K current report disclosing material items under Sections 4.01 and 9.01 of the Form 8-K.
- 2025-10-15: A Form 10-Q quarterly report was filed with the SEC, covering the quarter ended September 30, 2025.
- 2025-11-12 to 11-13: VSee will host VSeeCON 2025: AI & Digital Health User Conference in Silicon Valley, focusing on case studies in rural health, AI diagnostics, and next-generation medical devices.
Financial and Strategic Analysis
As of market close on 2025-10-16, VSEE shares traded at $0.7646, up 27.18% on a volume of 24,032,025 shares.
Key trailing-twelve-month metrics (per CNBC):
• Revenue: $10.42 million
• Gross margin: 68.87%
• Net margin: –553.69%
• EPS: –3.94
• P/E (TTM): –0.20
• EBITDA: –$3.30 million
• Market cap: $12.63 million
• Debt-to-equity: 49,786.37%
• YTD share-price change: –33.6%
Strategic initiatives include:
- Expansion of AI-driven telehealth modules for EHR vendors such as Oracle Cerner
- Partnerships with AbundaBox for health record aggregation and Ava Robotics for telepresence in critical care
- Integration with LanguageLine Solutions for multilingual interpretation
Market Position and Industry Context
The global digital healthcare market is projected to reach $787 billion. VSee competes with telehealth incumbents (Teladoc, Amwell) and general-purpose platforms (Zoom) by emphasizing clinical integration and medical device streaming. Its architecture allows healthcare organizations to deploy white-label solutions efficiently across various settings. The platform’s use by astronauts on the International Space Station highlights its emphasis on secure, low-bandwidth conferencing and medical-grade video.
tl;dr
On 2025-10-16, VSee Health’s stock increased by 27.18% to $0.7646 on NASDAQ, supported by ongoing contract developments and a recent quarterly SEC filing (Form 10-Q) for Q3 2025. The company is preparing for its VSeeCON conference on November 12–13, 2025, while continuing to pursue government and enterprise telehealth contracts and partnerships in AI diagnostics, record aggregation, and telepresence robotics. Upcoming milestones include Q3 financial results and early feedback from multi-year government programs valued at $6 million in the first year.
